Researchers compared treatment effectiveness among patients with rheumatoid arthritis and psoriatic arthritis with and without plan-level access restrictions to biologic or targeted disease-modifying antirheumatic drugs.
Researchers presented the outcomes from a 2-year intervention that included bone-strengthening physical activity and dietary behaviors of children attending after-school programs in the United States.
The European League Against Rheumatism developed recommendations for the collection, analysis, and use of big data in rheumatic and musculoskeletal disorders.
Researchers measured discordance between patient or family and physician global activity scores in juvenile dermatomyositis, and determined factors associated with discordance.
Researchers evaluated the frequency of polyautoimmunity and its associated factors in a large retrospective cohort of patients with systemic lupus erythematosus.
Researchers evaluated the role of adenosine deaminase 2 as a novel biomarker of macrophage activation syndrome.
Although fibromyalgia affects millions of Americans, the condition remains widely misunderstood. We debunk 5 common myths.
Effective for illnesses ranging from cancer to autoimmune diseases, biologics are among the most expensive prescription drugs in the United States.
Researchers assessed how clinicians should engage in shared decision making based on their patient’s personality type.
EULAR has released updated 2019 recommendations for the management of systemic lupus erythematosus.
